About ResMed
About ResMed
At ResMed, we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices, transform care for people with sleep apnoea, and other chronic diseases.
Our purpose
Our core purpose at ResMed is to inspire and energize the world through the power of better health.
We help hundreds of millions of people sleep better, breathe better, and live longer, happier, and higher-quality lives well away from a hospital. Everything we do at ResMed – the medical devices we design and build; the software solutions we provide; the culture we enable and scale; and the business ethics, integrity, and environmental stewardship with which we conduct business – is focused on the goal to help improve the lives of people in over 140 countries.
20.5M+ cloud-connectable devices
156M+ lives changed, last 12 months
14.5B+ nights of medical sleep & respiratory data
7.5M+ CPAP users have signed up for myAir
Sleep Apnea
An estimated 936 million people suffer from sleep apnoea or sleep suffocation – the upper airway closes off causing the body to jolt “awake” to take breaths throughout the night.1
ResMed provides: CPAP therapy that’s smaller, quieter, more comfortable, more connected.
4% fewer inpatient and emergency dept. visits for every nightly hour slept on CPAP2
39% lower all-cause mortality rate when treating sleep apnoea with CPAP3
87% patient adherence when remotely and self monitored4
COPD and lung diseases
An estimated 480 million people suffer from chronic obstructive pulmonary disease,5 the world’s third leading killer.6 ResMed provides the world’s most complete solution suite throughout a patient’s journey.
Cloud-connected invasive, non-invasive, and bilevel ventilation devices
Non-invasive ventilation (NIV) reduces one-year risk of death by 76%7
Propeller Health’s digital health platform is compatible with most COPD and asthma inhalers. It helps increase medication adherence by 58%8, reduce COPD-related emergency visits by 45%9, and decrease asthma-related emergency visits and hospitalizations by 57%.10
References:
1. Benjafield AV et al. Lancet Respir Med 2019
2. Kirsch DB et al. J Clin Sleep Med 2019
3. Pepin JL et al. Chest 2022
4. Malhotra A et al. Chest 2018
5. Boers E et al. ERJ Suppl (ERS Congress late-breaking abstract) 2022
6. WHO. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed Jun 19, 2020.
7. Garcia-Aymerich J et al. Thorax 2006
8. Van Sickle D et al. Eur Resp J 2016
9. Brazeal T et al. Abstract at European Respiratory Society 2021
10. Merchant R et al. World Allergy Organ J 2018
